Las Condes

265 / 320

669
24. Maddison A, Fisher J, Johnston G. Preventive medication use
among persons with limited life expectancy. Prog Palliat Care.
2011; 19(1): 15-21.
25. Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau C, et
al. Screening Tool of Older Persons’ Potentially inappropriate
prescriptions American Geriatrics Society 2015 Updated
Beers Criteria for Potentially Inappropriate Medication Use in
Older Adults. J Am Geriatr Soc. 2015; 63(11):2227-46.
26. Gill S, Mamdani M, Naglie G, Streiner D, Bronskill S, Kopp
A, et al. A Prescribing Cascade Involving Cholinesterase
Inhibitors and Anticholinergic Drugs. Arch Intern Med.
2005;165(7):808-13.
27. Delgado E, Montero B, Muñoz M, Vélez-Díaz-Pallarés
M, Lozano I, Sánchez-Castellano C, et al. Mejorando la
prescripción de medicamentos en las personas mayores: una
nueva edición de los criterios STOPP-START. Rev Esp Geriatr
Gerontol. 2015;50(2):89-96.
28. Kaye A, Baluch A, Scott J. Pain Management in the Elderly
Population – A Review. Ochsner J. 2010;10(3):179-187.
29. Mueller, S. K., Sponsler, K. C., Kripalani, S., & Schnipper, J. L.
(2012). Hospital-Based Medication Reconciliation Practices.
Archives of Internal Medicine, 172(14), 1–22. http://doi.
org/10.1001/archinternmed.2012.2246.
30. Doerper, S., Godet, J., Alexandra, J. F., Allenet, B., Andres, E.,
Bedouch, P., et al. (2015). Development and multi-centre
evaluation of a method for assessing the severity of potential
harm of medication reconciliation errors at hospital admission
in elderly. European Journal of Internal Medicine, 26(7),
491–497.
31. Silveira, E. D., García, M. M., Errasquin, B. M., Castellano, C.
S., Gallagher, P. F., & Cruz-Jentoft, A. J. (2009). Prescripción
inapropiada de medicamentos en los pacientes mayores
los criterios STOPP/START. Revista Española De Geriatría Y
Gerontología, 44(5), 273–279.
regg.2009.03.017.
32. Beers Criteria Update Expert Panel. (2015). American
Geriatrics Society 2015 Updated Beers Criteria for Potentially
Inappropriate Medication Use in Older Adults. Journal of the
American Geriatrics Society, 63(11), 2227–2246. http://doi.
org/10.1111/jgs.13702.
33. Kelly, O. B., Dillane, C., Patchett, S. E., Harewood, G. C., &
Murray, F. E. (2015). The Inappropriate Prescription of Oral
Proton Pump Inhibitors in the Hospital Setting: A Prospective
Cross-Sectional Study. Digestive Diseases and Sciences,
60(8), 2280–2286.
3642-8.
34. Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C.
N., Blum, C. B., Eckel, R. H., et al. (2014, June 24). 2013 ACC/
AHA guideline on the treatment of blood cholesterol to reduce
atherosclerotic cardiovascular risk in adults: a report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines. Circulation. http://doi.
org/10.1161/01.cir.0000437738.63853.7a.
35. Boeker, E. B., Ram, K., Klopotowska, J. E., de Boer, M., Creus,
M. T., de Andrés, A. L., et al. (2015). An individual patient
data meta-analysis on factors associated with adverse drug
events in surgical and non-surgical inpatients. British Journal
of Clinical Pharmacology, 79(4), 548–557. http://doi.
org/10.1111/bcp.12504.
36. Silva, C., Ramalho, C., Luz, I., Monteiro, J., & Fresco, P. (2015).
Drug-related problems in institutionalized, polymedicated
elderly patients: opportunities for pharmacist intervention.
International Journal of Clinical Pharmacy, 37(2), 327–334.
37. Armahizer, M. J., Kane-Gill, S. L., Smithburger, P. L., Anthes, A.
M., & Seybert, A. L. (2013). Comparing Drug-Drug Interaction
Severity Ratings between Bedside Clinicians and Proprietary
Databases. ISRN Critical Care, 2013(4), 1–6. http://doi.
org/10.5402/2013/347346.
38. Bennett, A., Gnjidic, D., Gillett, M., Carroll, P., Matthews,
S., Johnell, K., et al. (2014). Prevalence and Impact of Fall-
Risk-Increasing Drugs, Polypharmacy, and Drug–Drug
Interactions in Robust Versus Frail Hospitalised Falls Patients:
A Prospective Cohort Study. Drugs & Aging, 31(3), 225–232.
39. Juárez-Cedillo, T., Martinez-Hernández, C., Hernández-
Constantino, A., Garcia-Cruz, J. C., Avalos-Mejia, A. M.,
Sánchez-Hurtado, L. A., et al. (2015). Clinical Weighting
of Drug-Drug Interactions in Hospitalized Elderly. Basic
& Clinical Pharmacology & Toxicology, 118(4), 298–305.
40. Beers, M. H., Ouslander, J. G., Rollingher, I., Reuben, D. B.,
Brooks, J., & Beck, J. C. (1991). Explicit criteria for determining
inappropriate medication use in nursing home residents.
UCLA Division of Geriatric Medicine. (Vol. 151, pp. 1825–
1832). Presented at the Archives of internal medicine.
41. Beers, M. H. (1997). Explicit criteria for determining
potentially inappropriate medication use by the elderly. An
update. Archives of Internal Medicine, 157(14), 1531–1536.
42. Beers Criteria Update Expert Panel. (2012). American
Geriatrics Society Updated Beers Criteria for Potentially
Inappropriate Medication Use in Older Adults. Journal of the
American Geriatrics Society, 60(4), 616–631.
10.1111/j.1532-5415.2012.03923.
43. Burns M. Management of Narrow Therapeutic Index Drugs.
Journal of Thrombosis and Thrombolysis. 1999;7:137-143
44. National Kidney Fundation (2014) Frequently asked questions
About GFR estimates. 1–20.
45. Stevens, L. A., Nolin, T. D., Richardson, M. M., Feldman, H.
I., Lewis, J. B., Rodby, R., et al. (2009). Comparison of Drug
Dosing Recommendations Based on Measured GFR and
Kidney Function Estimating Equations. Yajkd, 54(1), 33–42.
46. Garasto, S., Fusco, S., Corica, F., Rosignuolo, M., Marino, A.,
Montesanto, A., et al. (2014). Estimating Glomerular Filtration
Rate in Older People. BioMed Research International, 2014(1),
1–12.
[EPIDEMIOLOGÍA DEL USO DE MEDICAMENTOS EN EL ADULTO MAYOR - Dr. Felipe Salech PhD y cols.]